We are live on
!
Find out more
BMS
Brummer Multi-Strategy Portfolio holdings
AUM
$24M
This Fund
S&P 500
This Quarter
Est. Return
+10.2%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.5M
AUM Growth
+$11.1M
(+201%)
Cap. Flow
+$11.1M
Cap. Flow
% of AUM
67.34%
Top 10 Holdings %
Top 10 Hldgs %
99.85%
Holding
13
New
9
Increased
2
Reduced
–
Closed
2
Top Buys
| 1 |
Cigna
CI
|
+$3.31M |
| 2 |
Arvinas
ARVN
|
+$1.82M |
| 3 |
IQVIA
IQV
|
+$1.78M |
| 4 |
ABVX
Abivax
ABVX
|
+$1.57M |
| 5 |
Maravai LifeSciences
MRVI
|
+$1.54M |
Top Sells
| 1 |
PTC Therapeutics
PTCT
|
+$1.17M |
| 2 |
Colliers International
CIGI
|
+$691K |
Sector Composition
| 1 | Healthcare | 77.93% |
| 2 | Real Estate | 21.01% |
| 3 | Materials | 1.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Newmark Group
NMRK
$2.67B
| $3.48M | 21.01% |
200,493
+10,974
| +6% | +$192K |
|
|
2
Cigna
CI
$79.6B
| $3.25M | 19.66% |
+11,818
| New | +$3.31M |
|
|
3
Arvinas
ARVN
$539M
| $1.97M | 11.93% |
+166,342
| New | +$1.82M |
|
|
ABVX
4
Abivax
ABVX
$11.8B
| $1.94M | 11.72% |
+14,375
| New | +$1.57M |
|
|
5
IQVIA
IQV
$34.8B
| $1.84M | 11.15% |
+8,183
| New | +$1.78M |
|
|
6
Maravai LifeSciences
MRVI
$953M
| $1.49M | 8.99% |
+457,707
| New | +$1.54M |
|
7
Becton Dickinson
BDX
$41.5B
| $1M | 6.07% |
5,176
+4,706
| +1,001% | +$896K |
|
8
AtaiBeckley Inc
ATAI
$2.08B
| $961K | 5.81% |
+234,915
| New | +$1.11M |
|
|
SLNO
9
DELISTED
Soleno Therapeutics
SLNO
| $405K | 2.45% |
+8,741
| New | +$479K |
|
|
GRML
10
Greenland Mines Ltd
GRML
$30.6M
| $175K | 1.06% |
+606,757
| New | +$291K |
|
11
Foghorn Therapeutics
FHTX
$316M
| $25.4K | 0.15% |
+4,708
| New | +$21.3K |
|
|
12
Colliers International
CIGI
$4.95B
| – | – |
-4,426
| Closed | -$691K |
|
|
13
PTC Therapeutics
PTCT
$6.63B
| – | – |
-19,142
| Closed | -$1.17M |
|
Similar funds
CC
BH
RL
BCM
BCM
SA
CG
IA